Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Completed 37Recruiting 14Active not recruiting 6Terminated 4Not yet recruiting 3No longer available 1Approved for marketing 1

Sponsor Class

OTHER 4INDUSTRY 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Genitourinary 1

Conditions

Lymphoma, Follicular 2Prostatic Neoplasms 1Multiple Myeloma 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Prednisolone × Clear all
NCT05295927 2025-02-03

A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)

Janssen Research & Development, LLC

Phase 1 Terminated
3 enrolled
Genitourinary

Prostatic Neoplasms

NCT01370694 2019-03-15

Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

Merck Sharp & Dohme LLC

Phase 1 Terminated
7 enrolled 7 charts
Lymphoid

Lymphoma, Follicular

NCT00562965 2018-01-09

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

Pfizer

Phase 3 Terminated
29 enrolled 14 charts
Lymphoid

Lymphoma, Follicular

NCT01179490 2013-03-18

Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma

SymBio Pharmaceuticals

Phase 2 Terminated
5 enrolled 30 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡